The Bondi mass measures the total mass-energy remaining in an isolated system at a retarded time, as defined at future null infinity. It is obtained by integrating the Bondi mass aspect over a sphere, with normalization set by the metric convention.

Outgoing gravitational radiation carries energy away, so the Bondi mass decreases by a nonnegative news-squared flux in the vacuum mass-loss formula. Additional outgoing matter contributes its own flux. This is distinct from the ADM mass defined at spatial infinity: the two quantities use different asymptotic cuts and account differently for radiation that has escaped.^[ref]

The Bondi shear is the leading trace-free angular distortion in an asymptotically flat spacetime described by Bondi-Sachs coordinates. In a common expansion, the angular metric is $h_{AB}=q_{AB}+C_{AB}/r+O(r^{-2})$, with $q^{AB}{C}_{AB}=0$.

Its retarded-time derivative determines the Bondi news function, with normalization depending on convention. The distinction matters: a nonzero but time-independent shear need not represent ongoing radiation, while changing shear describes radiative degrees of freedom. Changes between early and late configurations are also connected with gravitational memory.^[ref]

Bondi-Sachs coordinates $(u,r,x^A)$ follow outgoing null hypersurfaces. The retarded time $u$ labels the hypersurfaces, the angles $x^A$ label their null generators, and the areal radius $r$ fixes the angular area element. The coordinate conditions include $g_{rr}=g_{rA}=0$ and $\det g_{AB}=r^4\det q_{AB}$, where $q_{AB}$ is the unit-sphere metric.

Flat spacetime already illustrates the construction: setting $u=t-r$ in units $c=1$ gives $d{s}^2=-d{u}^2-2dudr+r^{2}d{\Omega }^2$. Constant-$u$ surfaces are outgoing light cones, although $g_{uu}$ is nonzero. The null condition concerns the hypersurface normal and gives $g^{uu}=0$.^[ref]

Thoracic gas volume, $V_{\mathrm{TG}}$, is the compressible intrathoracic gas volume assessed by body plethysmography at the instant of airway occlusion. It is not the volume of the entire thorax, which also contains tissues and fluid, and it does not identify a respiratory phase by itself.^[ref]

The phase matters when assigning a named capacity. In a constructed record, suppose the plethysmographic gas estimate is 3.2 L at an occlusion 0.4 L above the preceding quiet end-expiratory volume. If the measured increment and gas conditions are consistent, the corresponding functional residual capacity is $3.2-0.4=2.8$ L. Calling the unadjusted 3.2 L an FRC measurement would change the reference state without changing the observation.

The original experiment linked gas volume to pressure and inferred volume changes through Boyle's law.^[ref] In the small-change model,Thus a pressure-amplitude error can mimic extra gas volume. For an original illustration, let the actual gas volume be 2.8 L but the mouth signal represent only $7/8$ of the relevant alveolar pressure change. With all other terms unchanged, the inferred volume is $2.8/(7/8)=3.2$ L.

A second model can instead contain 2.8 L readily communicating with a tracer plus 0.4 L of compressible gas not reached during the tracer test. It can yield the same apparent 3.2 versus 2.8 L comparison. The numerical difference alone does not prove which model applies.

This is why comparison with helium dilution measurement of lung volume or nitrogen washout needs both compartment definitions and measurement assumptions. The technical standard describes the different accessible gas pools and potential pressure-equilibration errors.^[ref] Thoracic gas volume is a specific physical measurement, not a direct label for trapped gas or a substitute for every lung-volume definition.

Blood serum is the liquid recovered after blood has clotted and the clot and blood cells have been separated. In particular, fibrinogen has been converted into the fibrin network of the clot. Blood plasma is instead the liquid portion of blood whose clotting has been prevented, so it retains fibrinogen.^[ref]

A two-tube comparison makes the distinction concrete. Allow one sample to clot before centrifugation; prevent clotting in the other and then centrifuge it. Both yield liquid fractions, but the preparations have undergone different biochemical processes. Blood serum still contains many proteins, including antibodies; it is not a protein-free version of blood. Consequently an assay validated for one specimen type should not be interpreted as though sample preparation were irrelevant.

A blood cell is a cellular component of blood, including red blood cells and white blood cells. Red blood cells transport oxygen using hemoglobin; white blood cells participate in the immune system. The usual blood-count categories also include platelets, which in humans are cell fragments rather than complete nucleated biological cells.^[ref] Conversely, a mature human red blood cell is a whole specialized biological cell without a cell nucleus; possessing a cell nucleus is not a universal test for membership.

The Coulter counter connects cell counting to electric current. Wallace H. Coulter's patent passes a diluted suspension through a narrow conducting path between electrodes. A particle changes the electric current as it passes, yielding a countable pulse. The known sampled volume and dilution convert counts to an estimate for the original sample; simultaneous passage of particles can mask events.^[ref]

For a synthetic arithmetic example, count 5,000 cells in $1\mu \mathrm{L}$ of a sample diluted by a factor of 1,000. The original sample then contains an estimated $5000\times 1000/1=5,000,000$ cells per microlitre. This illustrates counting and dilution, not a clinical reference range. A pulse alone does not establish which cell type produced it; the preparation and classification method must specify that.

Arterial oxygen content is the amount of oxygen carried per specified volume of arterial blood. It includes oxygen bound to hemoglobin and oxygen dissolved in the liquid phase. It differs from oxygen partial pressure and from the fractional occupancy represented by oxygen saturation.^[ref]

A useful quantity model isHere $H$ is total hemoglobin concentration, $F_{{\mathrm{O}}_{2}Hb,a}$ the fractional oxyhemoglobin, $\beta$ a specified oxygen-binding conversion factor and $\alpha$ the dissolved-oxygen coefficient for the stated conditions. Units must be compatible: for example, $H$ in grams per decilitre and $\beta$ in millilitres oxygen per gram give a bound contribution in millilitres oxygen per decilitre blood.

Using the manufacturer's worked coefficient $\beta =1.34\mathrm{mL}{\mathrm{O}}_2{\mathrm{g}}^{-1}$, a chosen $H=15\mathrm{g}\mathrm{d}{\mathrm{L}}^{-1}$ and fraction $0.98$ give bound oxygen about $19.70\mathrm{mL}\mathrm{d}{\mathrm{L}}^{-1}$. Halving $H$ gives about $9.85$ despite unchanged fraction. The dissolved contribution must still be added for total content.^[ref] These are amount calculations, not clinical target values.

The saturation definition matters. Total hemoglobin can include carboxyhemoglobin and methemoglobin, so a fraction defined using only oxygenated plus deoxygenated functional hemoglobin should not automatically be multiplied by total $H$ as though every included form had the same oxygen-binding status.^[ref]

A primary 1989 instrument illustrates why carrier amount and saturation are separate observations: it illuminated whole blood in a capillary tube with red and infrared LEDs, detected scattered light and computed hemoglobin concentration and saturation from distinct signal relationships.^[ref]

For physiological transport, coronary oxygen delivery is flow times content. A pressure or saturation observation alone cannot supply that product without the remaining quantity information. The arterial sampling site, time and measurement definitions are part of the content result.

Venous oxygen content is the amount of oxygen per specified volume of blood sampled from a venous site. The site matters: a local tissue outflow, a coronary sinus mixture and a more widely mixed return need not have the same value. Venous describes a circulation route; the pulmonary vein carries blood returning from the lungs after oxygen uptake there.^[ref]

For a matched steady tissue balance,A chosen inflow content $C_a=0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$, flow $250\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$ and uptake $30\mathrm{mL}{\mathrm{O}}_2\mathrm{mi}{\mathrm{n}}^{-1}$ imply $C_v=0.08$. The value depends on uptake relative to flow, not simply on whether the sample is called venous.

Mixing obeys an oxygen-amount balance. For streams with compatible content definitions and negligible exchange during mixing,In an original example, flows $100$ and $50\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$ have contents $0.05$ and $0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$. Their mixture content is $0.10$, not the unweighted mean $0.125$. A mixed venous oxygen content is therefore defined by the contributing blood pools and their flows.

Like arterial oxygen content, venous content includes oxygen bound to hemoglobin and dissolved oxygen. A saturation number alone is not the same amount-per-volume quantity. The primary whole-blood oximeter study measured carrier concentration and saturation separately, illustrating the need to distinguish the inputs to a content calculation.^[ref]

The arteriovenous oxygen content difference should pair compatible territories and times before it is used to estimate coronary oxygen uptake. Comparing an arterial input with an unrelated venous mixture can combine different regions into a number that represents neither intended tissue balance.

The arteriovenous oxygen content difference is arterial oxygen content minus the venous oxygen content leaving the same tissue bed:It measures oxygen removed per unit volume of blood. For the whole body, the venous term is mixed venous oxygen content; for coronary oxygen uptake, the arterial and venous sampling sites must represent the coronary circulation. Oxygen content includes both hemoglobin-bound and dissolved oxygen, so this quantity is not simply the difference between two oxygen saturation readings.^[ref]

If $C_a=20$ and $C_v=15$ mL/dL, then $\Delta C_{{\mathrm{O}}_2}=5$ mL/dL. With blood flow $Q=50$ dL/min, the Fick principle gives oxygen consumption $Q\Delta C_{{\mathrm{O}}_2}=250$ mL/min. The same content difference at half the blood flow gives half the oxygen transfer. Conversely, at fixed oxygen transfer, a fall in blood flow requires a larger content difference in the steady-state balance.

Subtraction also has a useful measurement uncertainty structure. If $u_a,u_v$ are the standard uncertainties of the two content measurements, thenThe covariance term accounts for shared errors.^[ref] A common additive offset cancels in the difference, whereas a common multiplicative gain error scales the difference. Matched sampling and knowledge of shared measurement calibration errors can therefore matter as much as the repeatability of either measurement separately.

Oxygen consumption is the rate at which a system uses molecular oxygen in its chemical processes. In aerobic cellular respiration, oxygen participates in reactions supporting energy metabolism. The system boundary might be an isolated preparation, one tissue or the whole body; its definition determines which inflows, outflows and stored oxygen belong in the balance.

For a tissue supplied by blood flow $Q$, with compatible arterial oxygen content $C_a$ and venous oxygen content $C_v$, conservation giveswhen all terms use the same oxygen-amount or reference gas-volume basis. At steady oxygen storage,This is the oxygen form of the Fick principle. It measures net oxygen removal across the stated territory, not oxygen delivery alone.

An original example takes $Q=4.00$ L/min, $C_a=200$ mL oxygen/L and $C_v=140$ mL oxygen/L. Consumption is 240 mL oxygen/min, while arterial delivery is 800 mL/min. If tissue oxygen storage increases by an equivalent 10 mL/min, the same measured inflow–outflow difference instead permits consumption of 230 mL/min. Neglecting accumulation is an assumption to test, especially during transitions.

Respirometry supplies another route: measured gas inflow and outflow, or oxygen decline in a suitable closed chamber, constrain oxygen use. Chamber volume, leakage, sensor response and changes in stored gas or dissolved oxygen affect that inference. A falling oxygen signal is meaningful only after its amount basis and the system boundary are established.

A primary comparison of cardiac-output methods explicitly distinguished thermodilution from Fick output calculated using estimated oxygen uptake.^[ref] An assumed consumption value is not the same observation as direct measurement. Whole-body calculations also require mixed venous oxygen content, while a regional venous sample belongs with that region's flow. Report the measurement or estimation method alongside the resulting rate.

Response-range calibration of a bioassay equivalence margin chooses a curve-shape tolerance from the permitted change in relative biological potency over a specified response interval. It makes explicit why the same slope-ratio limit need not suit different response ranges. Here calibration means setting an assay-design tolerance, rather than measurement calibration of an instrument.

For an original local dose-response relationship, write $y_R=a_R+b_{R}z$ and $y_T=a_T+b_{T}z$, where $z$ is the natural logarithm of concentration and both slopes are positive. Equal-effect log-concentration separation is $\Delta z(y)=(y-a_R)/b_R-(y-a_T)/b_T$. Across a response interval of width $W$, its change is $W(1/b_R-1/b_T)$. Requiring the equal-effect concentration ratio to change by no more than a stipulated multiplicative tolerance $Q>1$ givesSet $s=b_T/b_R$ and $\eta =b_R\log Q/W$. For $0\le \eta <1$, the resulting bioassay parallelism equivalence margin isIf $\eta \ge 1$, this particular constraint supplies no finite upper bound on $s$; the lower bound remains $1/(1+\eta )$. The intercepts affect the potency level but cancel from its drift across the interval.

An original design example takes $W=0.8$ response units, $b_R=0.4$ response units per natural-log concentration, and $Q=1.1$. Then $\eta \approx 0.04766$, giving approximately $0.9545\le s\le 1.0500$. Halving the response interval doubles $\eta$ and relaxes these slope bounds. Rescaling the response measurement multiplies $W$ and $b_R$ together and leaves $\eta$ unchanged: the result depends on the experimental interval, not the arbitrary response units.

An equivalence test must still account for uncertainty in the estimated slope ratio. These local linear bounds do not establish matching plateaus in a nonlinear dose-response relationship. In the primary rituximab-standard collaborative study, analysts assessed multiple curve parameters and obtained study-specific limits from coded duplicates; those limits were explicitly not routine laboratory validity criteria.^[ref] Select the response interval and tolerated potency drift before inspecting the test preparation's disagreement.

An AVL tree is a binary search tree in which the left and right subtree heights differ by at most one at every vertex. The ordering invariant supports directed search; the extra height condition prevents the long chains that make an unbalanced binary search tree slow. Tree rotations repair the shape while preserving key order.^[ref]

Inserting keys 3,2,1 into an ordinary binary search tree produces a chain. A right tree rotation at three makes two the root with children one and three. For a height proof, count edges and set the empty-tree height to $-1$. The minimum vertex count satisfiesThis Fibonacci sequence growth gives height of a binary tree $O(\log n)$, hence logarithmic worst-case search, insertion and deletion time complexity. Deletion may require repairs at several ancestors.

A beta-decay spectrum gives the distribution of emitted electron or positron energies in beta decay. In ordinary three-body beta decay, the charged lepton shares the available energy with a neutrino and the recoiling daughter nucleus, producing a continuous spectrum.

For a simple allowed decay, its shape includes phase-space factors, an electron Coulomb correction and an endpoint set by the available energy. Schematically, $d\Gamma /dE\propto F(Z,E)pE(E_0-E{)}^2$ when the neutrino mass is neglected and $E$ is total electron energy. Nuclear matrix elements and forbiddenness can modify this expression. The continuum was central to understanding the missing energy carried by the neutrino.

The Anger function is the entire functionFor integer order $n$ it equals the first-kind Bessel function $J_n(z)$. At noninteger order it generally differs from $J_{\nu }$, despite the similar notation.^[ref]

The distinction appears in its inhomogeneous differential equation:Indeed, differentiating under the integral and integrating the derivative of $(\nu +z\cos \theta )\sin (\nu \theta -z\sin \theta )$ reduces the left side to its endpoint values, giving the displayed forcing. At integer order the forcing vanishes, consistently with the ordinary Bessel equation. This integral representation also makes analyticity in both the argument and the order visible.